The Cooper Companies, Inc. (COO)

Market Cap	11.34B -22.4%
Revenue (ttm)	4.24B +4.7%
Net Income	570.30M +39.8%
EPS	2.90 +42.4%
Shares Out	190.16M
PE Ratio	20.54
Forward PE	13.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	873,259
Open	58.70
Previous Close	59.88
Day's Range	58.50 - 60.29
52-Week Range	51.01 - 89.83
Beta	0.83
Analysts	Buy
Price Target	65.80 (+10.29%)
Est. Earnings	Dec 3, 2026

About COO

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 15,000
• Stock Exchange: Nasdaq
• Ticker Symbol: COO
• Website: https://www.coopercos.com

Financial Performance

In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.

Analyst Summary

According to 17 analysts, the average rating for COO stock is "Buy." The 12-month stock price target is $65.8, which is an increase of 10.29% from the latest price.

Price Target

$65.8

(10.29% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 28, 2026

Data Sources Report a data error